Thus, in TRAIL-resistant Huh-7 (R) and HCCLM3 (R) cells, CASC2 modulates HCC proliferation through the miR-18a/RIPK1 axis and the NF-κB signaling. Here, CASC2 is linked to hepatocellular carcinoma.